The Learning Portal will be under maintenance Monday, 6 December between 6 AM and 5 PM EST. Portal functionality will be unavailable during this window.
We apologize for any inconvenience caused during this time.

  • After Counterfeit Avastin Infiltrates Supply Chain, FDA Goes After Doctors

    The US Food and Drug Administration (FDA) is going after doctors in an attempt to protect the pharmaceutical supply chain from more instances of counterfeit medicines, reports Medscape News . There have been two instances of fake Avastin being found in the US in 2012-one in early April and another in mid-February . Both cases involved doctors deviating from approved suppliers to purchase Avastin from unauthorized wholesalers. While FDA Commissioner Margaret Hamburg ...
  • Study: Canadian Off-Label Prescribing Common, Lacks 'Strong Scientific Evidence'

    A new study released in the medical journal Archives of Internal Medicines finds nearly one-in-ten prescriptions written "off-label" in Canada lacked "strong scientific evidence" to support their prescribing, reports Health Day News . Off-label prescribing refers to applications for medicinal products that are not approved on its regulatory agency-approved label. In Canada, prescription drugs are regulated by Health Canada. The study, led by Dr. Tewodros Eguale of Mc...